Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

December 31, 2003

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Salmeterol/fluticasone propionate 50/500mcg Diskus

Trial Locations (20)

2400

GSK Investigational Site, København NV

10003

GSK Investigational Site, Cáceres

13419

GSK Investigational Site, Tallinn

28047

GSK Investigational Site, Madrid

51014

GSK Investigational Site, Tartu

90146

GSK Investigational Site, Palermo

DK-9100

GSK Investigational Site, Aalborg

00029

GSK Investigational Site, Helsinki

LT-44320

GSK Investigational Site, Kaunas

LT-50009

GSK Investigational Site, Kaunas

LT-08661

GSK Investigational Site, Vilnius

825 56

GSK Investigational Site, Bratislava

041 90

GSK Investigational Site, Košice

LE3 9QP

GSK Investigational Site, Leicester

NR4 7UZ

GSK Investigational Site, Norwich

NG5 1PB

GSK Investigational Site, Nottingham

NG7 2UH

GSK Investigational Site, Nottingham

HU16 5JQ

GSK Investigational Site, Hull

E2 9JX

GSK Investigational Site, London

E7 8QP

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY